Brief: 9 Meters Biopharma Announces Interim Analysis Of Phase 3 Study Of Larazotide For Celiac Disease Does Not Support Trial Continuation

9 Meters Biopharma

21/06/2022 14:59

June 21 (Reuters) - 9 Meters Biopharma Inc  NMTR.O :
    * 9 METERS BIOPHARMA ANNOUNCES INTERIM ANALYSIS OF PHASE 3
STUDY
OF LARAZOTIDE FOR CELIAC DISEASE DOES NOT SUPPORT TRIAL
CONTINUATION
    * 9 METERS BIOPHARMA INC - ADDITIONAL ANALYSES TO DETERMINE
IF A
SUBGROUP OF PATIENTS AND/OR SYMPTOMS MAY HAVE BEEN RESPONSIVE TO
TREATMENT
    * 9 METERS BIOPHARMA INC - REMAINS ON TRACK TO DELIVER
VUROLENATIDE PHASE 2 SHORT BOWEL SYNDROME RESULTS BY END OF
MONTH

Further company coverage:  NMTR.O